- About Us
- Nano-Social Network
- Nano Consulting
- My Account
July 20th, 2006
Abraxis BioScience: A SPARC for Explosive Growth?
Abraxis BioScience, Inc. (ABBI) provides a unique opportunity for investment in a biopharmaceutical company that is revolutionizing cancer therapy with its proprietary nanotechnology platform. Abraxis’ nanoparticle albumin-bound, or nab technology, exploits the natural properties of a human protein, albumin, for drug delivery.
|Related News Press|
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
New nano approach could cut dose of leading HIV treatment in half February 24th, 2017
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010